Myopic Choroidal Neovascularization
6 clinical trials · Condition
◉ Watch Myopic Choroidal Neovascularization
| Record | Firm | Date |
|---|---|---|
| A Study to Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV) (NCT04524910) | Bayer | 2021-06-16 |
| VEGF and PEDF in Patients With Myopic Choroidal Neovascularization (NCT02175940) | Università degli Studi di Brescia | 2013-07-01 |
| Ranibizumab for Myopic Neovascularization (NCT01246089) | Instituto de Olhos de Goiania | 2009-07-01 |
| Bevacizumab Intravitreal for Myopic Choroidal Neovascularization (NCT00797992) | Instituto de Olhos de Goiania | 2007-01-01 |
Track Myopic Choroidal Neovascularization automatically
Every clearance here is in the API, with alerts when new ones post.